Efficacy and Safety of Favipiravir in Treating COVID-19 Patients: A Meta-Analysis of Randomized Control Trials

This meta-analysis was conducted with the aim to assess the safety and efficacy of favipiravir in treating patients with coronavirus disease 2019 (COVID-19). It was carried out in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. We performed...

Descripción completa

Detalles Bibliográficos
Autores principales: Batool, Saima, Vuthaluru, Kiranmayi, Hassan, Amna, Bseiso, Omair, Tehseen, Zuha, Pizzorno, Guiomarly, Rodriguez Reyes, Yadelys, Saleem, Faraz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918851/
https://www.ncbi.nlm.nih.gov/pubmed/36788824
http://dx.doi.org/10.7759/cureus.33676

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918851/
https://www.ncbi.nlm.nih.gov/pubmed/36788824
http://dx.doi.org/10.7759/cureus.33676

Ejemplares similares